Tag Archives: BIPI

October, 2018

September, 2018

April, 2018

  • 5 April

    Boehringer Ingelheim and OSE Immunotherapeutics Enter Immuno-Oncology Partnership

    INGELHEIM, Germany & NANTES, France–(BUSINESS WIRE)–Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovative immunotherapies, today announced a collaboration and exclusive worldwide collaboration and license agreement to jointly develop OSE-172, a SIRP-alpha antagonist targeting myeloid lineage cells. SIRP-alpha is a receptor expressed by myeloid lineage …

November, 2017

June, 2017

December, 2016

  • 14 December

    FDA Approves Synjardy XR Tablets for Adults with Type 2 Diabetes

    RIDGEFIELD, Conn. and INDIANAPOLIS, Dec. 12, 2016 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Synjardy® XR (empagliflozin and metformin hydrochloride extended-release) tablets for adults with type 2 diabetes. When used along with diet and exercise, SYNJARDY XR is indicated to improve blood sugar in adults with …

October, 2016

April, 2016